Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.
Nanchahal J, Ball C, Swettenham J, Dutton S, Barber V, Black J, Copsey B, Dritsaki M, Taylor P, Gray A, Feldmann M, Lamb S. Nanchahal J, et al. Among authors: ball c. Wellcome Open Res. 2017 Nov 16;2:37. doi: 10.12688/wellcomeopenres.11466.2. eCollection 2017. Wellcome Open Res. 2017. PMID: 29218326 Free PMC article.
What do we know about managing Dupuytren's disease cost-effectively?
Dritsaki M, Rivero-Arias O, Gray A, Ball C, Nanchahal J. Dritsaki M, et al. Among authors: ball c. BMC Musculoskelet Disord. 2018 Jan 25;19(1):34. doi: 10.1186/s12891-018-1949-2. BMC Musculoskelet Disord. 2018. PMID: 29370792 Free PMC article. Review.
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
Nanchahal J, Ball C, Davidson D, Williams L, Sones W, McCann FE, Cabrita M, Swettenham J, Cahoon NJ, Copsey B, Anne Francis E, Taylor PC, Black J, Barber VS, Dutton S, Feldmann M, Lamb SE. Nanchahal J, et al. Among authors: ball c. EBioMedicine. 2018 Jul;33:282-288. doi: 10.1016/j.ebiom.2018.06.022. Epub 2018 Jul 6. EBioMedicine. 2018. PMID: 29983350 Free PMC article. Clinical Trial.
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial.
Nanchahal J, Ball C, Rombach I, Williams L, Kenealy N, Dakin H, O'Connor H, Davidson D, Werker P, Dutton SJ, Feldmann M, Lamb SE. Nanchahal J, et al. Among authors: ball c. Lancet Rheumatol. 2022 Jun;4(6):E407-E416. doi: 10.1016/S2665-9913(22)00093-5. Epub 2022 Apr 29. Lancet Rheumatol. 2022. PMID: 35949922 Free PMC article.
1,525 results